[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336563-105":59,"doc-detail-336563-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","anti-tumour-activity-of-panobinostat-in-oesophageal-adenocarcinoma-and-squamous-cell-carcinoma-cell-lines","Anti-tumour activity of Panobinostat - in oesophageal adenocarcinoma and squamous cell carcinoma cell lines","","Oesophageal cancer presents high mortality and limited treatment options, motivating evaluation of epigenetic therapies. This study assessed Panobinostat, an HDAC (histone deacetylase) inhibitor already approved for multiple myeloma, across oesophageal cell lines derived from normal and malignant origins representing adenocarcinoma and squamous cell carcinoma. Panobinostat suppressed growth, reduced proliferation, and impaired colony formation and invasion. HDAC1 increased in normal epithelium, while HDAC3 was overexpressed in cancer; HDAC2 and HDAC8 showed no differences. Panobinostat exposure diminished malignant features, suggesting HDAC3-linked therapeutic potential.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/anti-tumour-activity-of-panobinostat-in-oesophageal-adenocarcinoma-and-squamous-cell-carcinoma-cell-lines/336563/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/anti-tumour-activity-of-panobinostat-in-oesophageal-adenocarcinoma-and-squamous-cell-carcinoma-cell-lines/336563.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study on Panobinostat?","Question",{"text":113,"@type":114},"To evaluate the effect and biological consequences of Panobinostat treatment in oesophageal cell lines from normal and malignant sources representing adenocarcinoma and squamous cell carcinoma.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did Panobinostat affect oesophageal cancer cells in the results?",{"text":118,"@type":114},"Panobinostat inhibited cell growth and hindered proliferation, colony formation, and invasion of oesophageal cancer cells.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study find about HDAC expression patterns?",{"text":122,"@type":114},"HDAC1 was significantly upregulated in normal oesophageal epithelium versus tumour tissue, while HDAC3 was overexpressed in oesophageal cancer compared with non-malignant mucosa; HDAC2 and HDAC8 showed no differences.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},336563,1790188738,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Lopes et al. Clinical Epigenetics (2024) 16:102 [https://doi.org/10.1186/s13148-024-01700-3](https://doi.org/10.1186/s13148-024-01700-3)  \nClinical Epigenetics  \n RESEARCH Open Access  \nAnti-tumour activity of Panobinostat  \nin oesophageal adenocarcinoma and squamous cell carcinoma cell lines  \nNair Lopes1, Sofia Salta1,2, Bianca Troncarelli Flores 1, Vera Miranda‑Gonçalves 1,3, Margareta P. Correia 1,3, Davide Gigliano4, Rita Guimarães4, Rui Henrique 1,3,4 and Carmen Jerónimo1,3*  \nAbstract  \nBackground Oesophageal cancer remains a challenging disease with high mortality rates and few therapeutic options. In view of these difficulties, epigenetic drugs have emerged as potential alternatives for patient care. The goal of this study was to evaluate the effect and biological consequences of Panobinostat treatment, an HDAC (histone deacetylase) inhibitor already approved for treatment of patients with multiple myeloma, in oesophageal cell lines of normal and malignant origin, with the latter being representative of the two main histological subtypes: adenocar‑ cinoma and squamous cell carcinoma.  \nResults Panobinostat treatment inhibited growth and hindered proliferation, colony formation and invasion of oesophageal cancer cells. Considering HDAC tissue expression, HDAC1 was significantly upregulated in normal oesophageal epithelium in comparison with tumour tissue, whereas HDAC3 was overexpressed in oesophageal cancer compared to non‑malignant mucosa. No differences between normal and tumour tissue were observed for HDAC2 and HDAC8 expression.  \nConclusions Panobinostat exposure effectively impaired malignant features of oesophageal cancer cells. Because HDAC3 was shown to be overexpressed in oesophageal tumour samples, this epigenetic drug may represent an alter‑ native therapeutic option for oesophageal cancer patients.  \nKeywords Oesophageal cancer, Panobinostat, HDAC  \n*Correspondence: Carmen Jerónimo  \n[cljeronimo@icbas.up.pt](cljeronimo@icbas.up.pt); carmenjeronimo@ipoporto. min‑[saude.pt](saude.pt)  \n1 Cancer Biology and Epigenetics Group, Research Center of IPO Porto (CI‑IPOP)– CI‑IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto. CCC), Research Center‑LAB 3, F Bdg, 1st Floor, Rua Dr. António Bernardino de Almeida, 4200‑072 Porto, Portugal  \n2 Doctoral Program in Pathology and Molecular Genetics, ICBAS – School of Medicine and Biomedical Sciences – University of Porto (ICBAS‑UP), Rua de Jorge Viterbo Ferreira, 228, 4050‑313 Porto, Portugal  \n3 Department of Pathology and Molecular Immunology, ICBAS‑School of Medicine and Biomedical Sciences, University of Porto (ICBAS‑UP), Ruade Jorge Viterbo Ferreira, 228, 4050‑313 Porto, Portugal  \n4 Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto. CCC), Rua Dr. António Bernardino de Almeida, 4200‑072 Porto, Portugal  \nBackground  \nOesophageal cancer is a major health burden worldwide, with high mortality rates [1]. This is a heterogenous disease, composed of two main histological subtypes: squamous cell carcinoma (SCC) and adenocarcinoma (AC). Although these tumours represent different biological entities with distinct molecular features, they share poor survival rates [1–3]. This is presumably a consequence of the disease being diagnosed at advanced stages due to difficulties in screening and the lack of specific targeted therapies [4]. Therefore, considering the high mortality rates of oesophageal cancer, research is now focused on new therapeutic options and also biomarkers allowing for early diagnosis.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution‑NonCommercial‑NoDerivatives 4.0 International License, which permits any non‑commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original a","cbCaifXkhtS1odrp","https://ap.wps.com/l/cbCaifXkhtS1odrp","pdf",1973875,"English","# Abstract\n## Background\n## Results\n## Conclusions\n## Keywords","[{\"question\":\"What is the main objective of the study on Panobinostat?\",\"answer\":\"To evaluate the effect and biological consequences of Panobinostat treatment in oesophageal cell lines from normal and malignant sources representing adenocarcinoma and squamous cell carcinoma.\"},{\"question\":\"How did Panobinostat affect oesophageal cancer cells in the results?\",\"answer\":\"Panobinostat inhibited cell growth and hindered proliferation, colony formation, and invasion of oesophageal cancer cells.\"},{\"question\":\"What did the study find about HDAC expression patterns?\",\"answer\":\"HDAC1 was significantly upregulated in normal oesophageal epithelium versus tumour tissue, while HDAC3 was overexpressed in oesophageal cancer compared with non-malignant mucosa; HDAC2 and HDAC8 showed no differences.\"}]","Anti-tumour activity of Panobinostat - in oesophageal adenocarcinoma and squamous cell carcinoma cell lines | PDF",1790015616,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b803d5da24b0149c98aa2af6437d0b2f.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79e8821f1f660a39c9420915a5e3504d.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/411820d203845a5835e016d53999b441.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0cf851e3ea03bd36225a122b050f141.webp",980,1301]